CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults.
Tonny VeenithBenjamin A FisherDaniel SladeAnna RoweRowena SharpeDavid R ThickettTony WhitehouseMatthew RowlandJames ScrivenDhruv ParekhSarah J BowdenJoshua S SavageDuncan RichardsJulian BionPamela KearnsSimon Gatesnull nullnull nullPublished in: BMJ open (2021)
EudraCT2020-001684-89, ISRCTN40580903.
Keyphrases
- phase ii
- open label
- clinical trial
- phase iii
- study protocol
- double blind
- phase ii study
- randomized controlled trial
- coronavirus disease
- sars cov
- placebo controlled
- ionic liquid
- room temperature
- squamous cell carcinoma
- risk assessment
- climate change
- respiratory syndrome coronavirus
- carbon dioxide
- human health
- community acquired pneumonia
- gold nanoparticles
- highly efficient